Conversely, HS‐10352 displayed no inhibitory effects on cell lines lacking PIK3CA mutations, like the human breast cancer HDQ‐P1 cell line and the human gastric cancer SNU‐1 and MKN‐74 cell lines. This evidence concerns the gene PIK3CA and breast carcinoma.